These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 10098513

  • 1. Activin and inhibin binding to the soluble extracellular domain of activin receptor II.
    Donaldson CJ, Vaughan JM, Corrigan AZ, Fischer WH, Vale WW.
    Endocrinology; 1999 Apr; 140(4):1760-6. PubMed ID: 10098513
    [Abstract] [Full Text] [Related]

  • 2. Effect of adenovirus-mediated overexpression of follistatin and extracellular domain of activin receptor type II on gonadotropin secretion in vitro and in vivo.
    Leal AM, Takabe K, Wang L, Donaldson CJ, MacConell LA, Bilezikjian LM, Verma IM, Vale W.
    Endocrinology; 2002 Mar; 143(3):964-9. PubMed ID: 11861519
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the extracellular ligand-binding domain of the type II activin receptor.
    Greenwald J, Le V, Corrigan A, Fischer W, Komives E, Vale W, Choe S.
    Biochemistry; 1998 Nov 24; 37(47):16711-8. PubMed ID: 9843440
    [Abstract] [Full Text] [Related]

  • 4. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
    Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W.
    Nature; 2000 Mar 23; 404(6776):411-4. PubMed ID: 10746731
    [Abstract] [Full Text] [Related]

  • 5. Tissue-specific binding of radiolabeled activin A by activin receptors and follistatin in postimplantation rat and mouse embryos.
    Roberts VJ, Bentley CA, Guo Q, Matzuk MM, Woodruff TK.
    Endocrinology; 1996 Oct 23; 137(10):4201-9. PubMed ID: 8828478
    [Abstract] [Full Text] [Related]

  • 6. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism.
    Xu J, McKeehan K, Matsuzaki K, McKeehan WL.
    J Biol Chem; 1995 Mar 17; 270(11):6308-13. PubMed ID: 7890768
    [Abstract] [Full Text] [Related]

  • 7. Identification of a binding site on the type II activin receptor for activin and inhibin.
    Gray PC, Greenwald J, Blount AL, Kunitake KS, Donaldson CJ, Choe S, Vale W.
    J Biol Chem; 2000 Feb 04; 275(5):3206-12. PubMed ID: 10652306
    [Abstract] [Full Text] [Related]

  • 8. Ovarian regulation of pituitary inhibin subunit and activin receptor type II gene expression: evidence for a nonsteroidal inhibitory substance.
    Dalkin AC, Gilrain JT, Marshall JC.
    Endocrinology; 1994 Sep 04; 135(3):944-9. PubMed ID: 8070390
    [Abstract] [Full Text] [Related]

  • 9. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
    Takumi T, Moustakas A, Lin HY, Lodish HF.
    Exp Cell Res; 1995 Jan 04; 216(1):208-14. PubMed ID: 7813622
    [Abstract] [Full Text] [Related]

  • 10. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice.
    Coerver KA, Woodruff TK, Finegold MJ, Mather J, Bradley A, Matzuk MM.
    Mol Endocrinol; 1996 May 04; 10(5):534-43. PubMed ID: 8732684
    [Abstract] [Full Text] [Related]

  • 11. Monomeric activin A retains high receptor binding affinity but exhibits low biological activity.
    Hüsken-Hindi P, Tsuchida K, Park M, Corrigan AZ, Vaughan JM, Vale WW, Fischer WH.
    J Biol Chem; 1994 Jul 29; 269(30):19380-4. PubMed ID: 8034704
    [Abstract] [Full Text] [Related]

  • 12. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.
    Lebrun JJ, Vale WW.
    Mol Cell Biol; 1997 Mar 29; 17(3):1682-91. PubMed ID: 9032295
    [Abstract] [Full Text] [Related]

  • 13. Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer.
    Kleeff J, Ishiwata T, Friess H, Büchler MW, Korc M.
    Int J Cancer; 1998 Sep 11; 77(6):860-8. PubMed ID: 9714055
    [Abstract] [Full Text] [Related]

  • 14. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
    Alexander JM, Bikkal HA, Zervas NT, Laws ER, Klibanski A.
    J Clin Endocrinol Metab; 1996 Feb 11; 81(2):783-90. PubMed ID: 8636304
    [Abstract] [Full Text] [Related]

  • 15. Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase.
    Greenwald J, Fischer WH, Vale WW, Choe S.
    Nat Struct Biol; 1999 Jan 11; 6(1):18-22. PubMed ID: 9886286
    [Abstract] [Full Text] [Related]

  • 16. Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins.
    Farnworth PG, Wang Y, Leembruggen P, Ooi GT, Harrison C, Robertson DM, Findlay JK.
    J Endocrinol; 2006 Mar 11; 188(3):451-65. PubMed ID: 16522726
    [Abstract] [Full Text] [Related]

  • 17. Dynamic regulation of pituitary follistatin messenger ribonucleic acids during the rat estrous cycle.
    Halvorson LM, Weiss J, Bauer-Dantoin AC, Jameson JL.
    Endocrinology; 1994 Mar 11; 134(3):1247-53. PubMed ID: 8119165
    [Abstract] [Full Text] [Related]

  • 18. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.
    Li Q, Kumar R, Underwood K, O'Connor AE, Loveland KL, Seehra JS, Matzuk MM.
    Mol Hum Reprod; 2007 Sep 11; 13(9):675-83. PubMed ID: 17704537
    [Abstract] [Full Text] [Related]

  • 19. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.
    Yamashita H, ten Dijke P, Huylebroeck D, Sampath TK, Andries M, Smith JC, Heldin CH, Miyazono K.
    J Cell Biol; 1995 Jul 11; 130(1):217-26. PubMed ID: 7790373
    [Abstract] [Full Text] [Related]

  • 20. Stimulation of activin receptor II signaling pathways inhibits differentiation of multiple gastric epithelial lineages.
    Li Q, Karam SM, Coerver KA, Matzuk MM, Gordon JI.
    Mol Endocrinol; 1998 Feb 11; 12(2):181-92. PubMed ID: 9482661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.